| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5841732 | Life Sciences | 2015 | 10 Pages |
Abstract
The activation of ECS by inhibiting the degradation of AEA is an effective pharmacological approach to suppress Aβ-induced neuropathic injury. Our research could result in a more realistic alternative for AD treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hengjing Cui, Rui Yang, Sha Liu, Guohui Fu, Yang Lu,